The clinical relevance of BAFF has also been supported by prior studies in HBV-related hepatocellular carcinoma, where elevated plasma BAFF levels were independently associated with tumor progression, invasiveness, and overall survival [52,53]. The gene discussed is TNFSF13B; the disease is hepatocellular carcinoma.